WINCAP FINANCIAL LLC

Position in MRK — Merck & Co., Inc.

CIK 2064588 BOSTON, MA

Position in MRK

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$1,558,705

+$132,547 QoQ

Shares Held

12,130

+2.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.59%

of 13F equity value

Holder Rank

#1,765

of 3,769 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

WINCAP FINANCIAL LLC holds $8,253,715 across 6 Drug Manufacturers - General names. MRK ranks #2 (18.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	10,261	$2,582,078
2	MRK	Merck & Co., Inc. This page	12,130	$1,558,705
3	BMY	Bristol Myers Squibb Co	23,756	$1,368,820
4	PFE	Pfizer Inc	46,496	$1,119,623
5	AMGN	Amgen Inc	2,444	$885,021
6	GILD	Gilead Sciences, Inc.	5,853	$739,468

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,558,705	12,130	+2.3%	Shares	Sole	2026-07-09
2026-03-31	$1,426,158	11,856	+12.0%	Shares	Sole	2026-04-09
2025-12-31	$1,114,492	10,588	-2.5%	Shares	Sole	2026-01-14
2025-09-30	$911,731	10,863	-1.5%	Shares	Sole	2025-11-07
2025-06-30	$872,580	11,023	-0.4%	Shares	Sole	2025-08-01
2025-03-31	$993,014	11,063	+18.4%	Shares	Sole	2025-05-07
2024-12-31	$929,541	9,344	—	Shares	Sole	2025-05-07
No filing history on record for this holder in this stock.